Healthcare Press Releases

ROCKVILLE, MD, UNITED STATES, October 18, 2018 /EINPresswire.com/ — American Gene Technologies (AGT), a leading gene and cell therapy company in the discovery and development of lentiviral vector based therapeutics, announces that the U.S. Food and Drug Administration (FDA) received orphan-drug designation #DRU-2018-6572 for the treatment of phenylketonuria (PKU) using its proprietary, lentiviral vector based technology. PKU is a debilitating inherited disease affecting 1 in 13,500 children born in the U.S. Mandatory screening identifies affected children who can be supported with a strict synthetic diet that does not cure disease. If successful, AGT's lentiviral vector approach will provide a permanent cure, improving quality of life for more than 16,000 people living with PKU in the U.S. alone.

“We are pleased to receive this orphan drug designation from the FDA for AGT’s vector technology to treat PKU. Our technology demonstrates promising potential to address an unmet medical need in treating this rare disease,” said Jeff Galvin, CEO and Founder of AGT. “We believe this orphan designation will enable AGT to formally shape and advance its PKU program.”

About American Gene Technologies (AGT):

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including: large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

Website: www.americangene.com

American Gene Technologies Contacts:

C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269
Email: info@americangene.com

Media Contact: Sasha Whitaker, swhitaker@americangene.com
American Gene Technologies
(301) 337-2100
email us here

Source: EIN Presswire

Nexien BioPharma's new trading symbol: NXEN

Nexien BioPharma Inc (OTCQB:NEXN)

DENVER, CO, USA, October 18, 2018 /EINPresswire.com/ — Nexien BioPharma Inc. (OTCQB: NXEN) (formerly Intiva BioPharma Inc.) (the "Company") today announced that effective as of October 19, 2018, the Company will trade on the OTC QB under the new stock symbol NXEN.

Commenting on the symbol change, Alain Bankier, the Interim CEO of Nexien stated, “ The new symbol, NXEN, is more reflective of our Corporate name, Nexien BioPharma and our objective of being a global leader in the further evolution of cannabinoid science and the development of Food and Drug Administration ("FDA") compliant pharmaceuticals based on specific cannabinoid molecules.”
About Nexien BioPharma
Nexien BioPharma is a US-based pharmaceutical development company engaged in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals in accordance with U.S. Food and Drug Administration ("FDA") pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders.
Nexien BioPharma's drug development strategy consists of:
• The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;
• Conducting "freedom to operate" investigations on these conditions;
• The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;
• Identifying the regulatory pathway with the FDA; and
• Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).
Current financial disclosure and Real-Time Level 2 quotes for Nexien Biopharma are available at www.otcmarkets.com or at www.INTIVABioPharma.com.

Nexien Disclosure Notice: This press release contains "forward-looking statements. For this purpose, any statements contained herein or which are otherwise made by or on behalf of Nexien BioPharma that are not statements of historical facts may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "should," "would," "estimate," or "continue," or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Readers are cautioned that all forward-looking statements involve risk and uncertainties, which may cause results to differ materially from those, set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; Nexien BioPharma's ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to events outside of Nexien BioPharma's control.
Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. Nexien BioPharma undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

Mark Lubchenco
Nexien BioPharma Inc
303 495 7583
email us here

Source: EIN Presswire

A bed that converts into a lift chair and safely puts your loved one or patient in bed and allows them to get out of bed without help.

ORLANDO, FL, UNITED STATES, October 18, 2018 /EINPresswire.com/ — After successful completion and extended product testing and evaluation, HMS has secured a nationwide exclusive distribution agreement for the My Freedom Lift Bed. Being first to market, The My Freedom Lift Bed artfully combines the benefits of a lift chair with a fully electric hospital bed. The Advanced model retails at $7,995 and is equipped with the GreatCall® monitoring system and also offers an optional air adjustable mattress topper to maximize patient comfort.

Neither Traditional hospital beds or leisure consumer adjustable beds provide for ease of transfer to a standing position and often require assistance from others. Lift chairs do not provide the support and comfort of a luxury mattress which makes sleeping or even spending an extended amount of time in them problematic for many. The My Freedom Lift Bed combines the ease of standing with a lift chair and the comfort of a leisure adjustable bed with the Hi-Lo feature of a fully electric hospital bed at one low attractive price. The Advanced model is backed with a ten-year limited warranty. Monthly rental programs are also available.

Over 1.5 million people currently reside in nursing homes nationwide. New regulations mandating a minimum of two staff members to assist a resident out of bed for transfer will add millions to institutional staffing costs. The My Freedom Lift Bed can eliminate the need for the two-person assistance requirement as well as allow the patient or resident their freedom and pride with unassisted entry and exit from the bed.

Being a Florida based company, HMS selected Orlando, Tampa, St. Pete Florida as the first markets to launch the new My Freedom Lift Bed Basic and Advanced model. With nearly 2,000 Assisted Living Centers in Florida, Central Florida is home to many of the top rated Assisted Living and Skilled Nursing Home facilities providing a unique opportunity to market the My Freedom Lift Bed. The response has been overwhelming and there is now a wait list for the next supply arriving in early December. HMS greatly underestimated the acceptance of the My Freedom Lift Bed and has stepped up production to match the increasing demand.

Tom Wasman
HMS Guest Experience
321-800-2121
email us here

Source: EIN Presswire

Visitors view panel on Industry of Death by CCHR at Church of Scientology Tampa

TAMPA, FLORIDA, USA, October 18, 2018 /EINPresswire.com/ — On World Mental Health Day, October 10th, a panel of experts spoke out against the psychiatric drugging of youth at the Church of Scientology Tampa in Ybor Square. The panel included Diane Stein, President Citizens Commission on Human Rights (CCHR) Florida, local physician Dr. Richard Wallace, School Principal Barbie Rivera, and Clinical Psychologist Dr. Candace Stewart-Sabin. They addressed a group of over 50 mental health professionals, child advocacy/education specialists and interested citizens.

About CCHR:

Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969.

Pat Harney
Church of Scientology Flag Service Organization
727-467-6860
email us here

Source: EIN Presswire

These pills, falsely sold as “all natural,” do not disclose that they contain Viagra. Viagra and similar prescription drugs can cause death or serious injury if taken without a doctor’s supervision.

Rhino-brand pills are dangerous

For the second time in a week, a judge allows lawsuits against Rhino retailers to proceed

LOS ANGELES, CALIFORNIA, USA, October 18, 2018 /EINPresswire.com/ — Gas station owners who claim they are doing nothing illegal by selling Viagra-laced pills lost another attempt at getting a court to dismiss the lawsuits against them.

A Los Angeles superior court judge on Tuesday said lawsuits should proceed against the gas stations for selling Rhino brand pills, including unlawful sales of prescription drugs, false and misleading advertising, and risks to customers health and safety. The ruling comes after an Oct. 10 ruling by a superior court judge in Santa Monica, who also said lawsuits could proceed against retailers in that city selling Rhino pills.

The lawsuits accuse the defendants of engaging in unfair competition and false advertising by selling falsely-labeled “all natural” and “safe” male enhancement pills that in reality contain the prescription drug sildenafil – the active ingredient in Viagra.

In the latest motion to dismiss, MV Petroleum Corp. and Overland Mobil Mart argued that selling Rhino pills is legal, that they didn’t participate in any false advertising, and that federal laws against false advertising didn’t apply because their stores do not engage in interstate commerce.

Superior Court Judge Michael Linfield disagreed, writing that, first of all, selling undisclosed prescription drugs and representing that the pills require no prescription “is unlawful.” As for the allegations of engaging in false and misleading advertising, he wrote, it is sufficient “that the products are mislabeled at the point of purchase. Consumers are likely to be misled by representations that the products do not contain chemicals or require a prescription.”

As to violating the federal law against unfair competition and false advertising, Linfield ruled that the defendants raised no objections to the lawsuit’s accusation of their being part of a conspiracy with Rhino distributors and manufacturers who operate nationally. “Defendants may be seen as operating on the same level as plaintiffs,” he wrote.

“These rulings make it crystal clear to retailers selling adulterated supplements that they should put an end to their unlawful practices,” said Robert Tauler, a principal at Tauler Smith LLP, in Los Angeles and a nationally-recognized expert in adulterated health supplements and false advertising law. The lawsuit alleges that distributors often assure retailers they are not doing anything illegal and even provide counterfeit FDA documents to convince them. “The law states that if you are disseminating false statements on these products by selling them in your store, you are liable,” Tauler said.

Using Viagra without a doctor’s supervision can result in serious penile injuries (blood clots and amputation, for instance), heart attacks, stroke and vision problems. Men have died after taking Viagra-laced “all natural” erectile dysfunction pills like those identified in the suit.

Tauler represents Houston-based Outlaw Laboratory LP, which makes competing natural products sold in all 50-states that meet strict FDA dietary supplement regulations. Federal law allows competitors to sue retailers for false advertising if products are adulterated. The products named in the lawsuit do not disclose the presence of hidden drugs such as sildenafil, tadalafil and dapoxetine on their labels.

About Tauler Smith LLP
Tauler Smith LLP specializes in high-stakes commercial litigation representing both plaintiffs and defendants in a variety of areas, including business disputes, false advertising, the foreign corrupt practices act, and unfair competition

Robert Tauler
Tauler Smith LLP
310-590-3927
email us here

WDIV 4 Detroit: Gas stations in Metro Detroit sued for selling Viagra to unsuspecting customers

Source: EIN Presswire

Join Cellements in Atlanta, GA on Oct. 18

Biopocket sprays fit in your pocket

All Natural Bio Tech products

US Cellements Launch Tour is on the go and is coming to Atlanta on October 18.

ATLANTA, GEORGIA, UNITED STATES, October 18, 2018 /EINPresswire.com/ — Mr. Anders Karlsson, CEO & Founder of Cellements and Mr. Nicolas Andreasson, Global Master Distributor are coming to Atlanta and invite you to join them in learning more about the BioPocket line of products that revolutionized Europe.

Cellements, a biotechnology company launches its products in the USA in a tour that started on October 13 in Detroit, Michigan and has several destinations in the US: San Diego (October 15), Pheonix (October 16 & 17), Atlanta (October 18) and Minneapolis (October 19).

One of the key stops will happen on October 18, when the Cellements’ team stops in Atlanta for an amazing launch event. Atlanta is seen as the favorite city among entrepreneurs and international companies, as the Atlanta metropolitan area's economy is considered the tenth-largest in the country and among the top 20-largest in the world. Moreover, the city claims the nation's third-largest concentration of Fortune 500 companies, and is home to various multinationals as The Coca-Cola Company, Delta Air Lines, and UPS.

Cellements brought together a team of international experts in the Bio Tech industry to make sure their BioPocket line of products is effective, user friendly, and most important environment-friendly. From an alchool-free hand and screen spray, that is designed to keep you and your cellphone protected against any bacteria, to a natural insect repellent, an energy booster, a natural sleep aid, an antioxidant spray, and others, the BioPocket series of products are all Made in Sweden, a leading country in product development and banned GMOs.

The most popular among them seems to be the antibacterial formula of Biopocket handspray proven to be 99.99% capable of killing germs and is absolutely safe to use with no side effects. Unlike other products, its solution is alcohol-free and dermatologically tested to cause no skin dryness and irritation.

Not many people knoe that our phones are dirtier than we think. A study conducted in UK, suggested our phones exceed the acceptable total viable bacterial count level. In fact they are 18 times dirtier than the public restroom toilet flush and are most probably carrying fecal matters.

Biopocket handspray is a portable handspray to fight off germs found in your hands and on your phone. The best part of this is that Cellements developed an app dedicated to reminding you when you need to clean your phone. The app is available for download in Google Play and App Store.

“Our Pocket Concept is designed to fit into the trend of making your life easier and more fun. At the same time giving you a better health and quality of life,” said Anders Karlsson, CEO & Founder of Cellements.

Nicolas Adreasson, a US based entrepreneur and founder of multiple successful businesses partnered with Cellements® to bring the world this unique line of Bio Tech products for a healthy lifestyle. When asked about the US Cellements Launch Tour he replied: “I am beyond excited to be on this tour. These products are made with the newest revolutionizing Biotechnology processes. Conveniently packaged, same size as a credit card, they can be carried anywhere.”

The launch in Atlanta, GA will take place between 7-9 PM EST. at Hotel Indigo, 1776 Harvard Ave, College Park, GA 30337. For more info call 248-760-3241.

Cellements’ products can be ordered online at usa.cellements.com and are shipped within 24 hours directly to your door. Those interested in the innovative idea, have also the opportunity to join the business and become part of the team by sharing the products to family and friends.

Cellements USA
Press Center
248-760-3241
email us here

Source: EIN Presswire

Benjamin Caplan, M.D.

Benjamin Caplan, MD, Founder of CED Foundation and Chief Medical Officer of solo sciences inc (solo*), Featured as Expert

BOSTON, MA, USA, October 18, 2018 /EINPresswire.com/ — Benjamin Caplan, MD, founder of both CED Clinic and CED Foundation as well as the Chief Medical Officer for solo sciences inc, was published in the “Clinical Decisions” feature in The New England Journal Medicine (NEJM). The popular, interactive “Clinical Decisions” series presents a medical issue in a vignette and then asks two physicians to present opposing views on a given treatment option. Readers then participate by choosing a side and providing their reasoning.

The vignette published today examines the case of a 31-year-old woman being prescribed opioids for complex long-standing regional pain. The two experts argued on why, in their opinions, medicinal cannabis should be prescribed or discouraged. Dr. Caplan presented the case for prescribing cannabis. He defended his position by noting many beneficial medical aspects of cannabis. Among those mentioned were its advantages as an analgesic over opioids, its anti-inflammatory and neuroprotective effects, as well as its ability to create a reduced stress response to the patient’s condition.

Ashesh (Alex) Shah, Founder and CEO of solo sciences inc. (solo*), complimented Dr. Caplan’s participation and expertise: “We are delighted to see Dr. Caplan’s work published in The New England Journal of Medicine. As the expert voice for solo* on topics such as the safety and efficacy of medicinal cannabis as well as the need for enhanced trust and transparency in the cannabis industry, we congratulate Ben. We also believe NEJM should be acknowledged for providing a platform for discourse regarding cannabis treatment options as they become more mainstream.”

About solo sciences inc  
solo sciences inc (solo*) is an independent auditor of information and a conduit to collect direct consumer feedback. The Company’s primary mission is to protect consumers by filtering brands and simplifying the purchasing process. By evaluating the business practices and products of participating brands, and allowing those that qualify to become solo* Members, solo* provides consumers with objective, third-party verification of brands and products in a new industry that is still difficult to navigate for many consumers. Founded in December 2017, and with offices in Boston, New York, and Los Angeles, the solo* team united people from backgrounds in finance, industry, branding, and medical research to generate a technology that could create trust and transparency in the marketplace.
To learn more, visit solosciences.com  

About CED Foundation
Created in 2017, CED Foundation was established with a single-minded purpose: to empower physicians and patients who need access to medicinal cannabis as an option in effective treatment plans. The Foundation strives to address a decades long campaign against medicinal cannabis which has resulted in a plague of misinformation that tragically stripped patients of a safe, and often desperately needed, medical option.

About CED Clinic
CED Clinic was formed in 2017 in order to provide medical services and oversight to individuals seeking cannabis treatment. With an ever-increasing amount of research linking cannabis to positive treatment outcomes, the clinic strongly supports a holistic approach to healthcare and wellness that includes medicinal cannabis. The clinic’s mission is to provide a comfortable and professional environment where patients and physicians can openly discuss medical cannabis and its benefits. The clinic offers comprehensive treatment oversight and has seen medicinal cannabis help patients overcome a wide variety of diseases. Among other ailments, CED Clinic patients have overcome emotionally devastating PTSD, quality-of-life destroying Lupus, the paralyzing effects of severe epilepsy, and debilitating chronic pain issues that had previously only been treatable using a litany of highly addictive opioids.

About Benjamin Caplan, MD.
Dr. Caplan (BA, Williams, 2003; MD, Tufts, 2010), a Boston native, speaks widely across the nation on the health benefits of cannabis. In the past 16 years, across 10 states, he has overseen 250,000 patients who reaped the health and benefits of medicinal cannabis. Patients in his practice present with a wide range of symptoms and ailments, and a clear majority experience relief, many after long and relatively unsuccessful traditional treatments.

Kimberly Macleod
kmacconnect
917.587.0069
email us here

Source: EIN Presswire

Global Corporate Wellness Market Overview and Forecast 2023

Arizton Advisory and Intelligence

global corporate wellness market share analysis 2023

global corporate wellness market trends and drivers 2023

Global Corporate wellness Market – Major Companies

The global corporate wellness market is anticipated to reach values of around $72 billion by 2023, growing at a CAGR of more than 8% during 2017-2023.

CHICAGO, IL, UNITED STATES, October 18, 2018 /EINPresswire.com/ — Arizton’s recent market research report on the global corporate wellness market identifies Compsych, Wellness Corporate Solutions, Virgin Pulse, Provant Health Solutions, and Sodexo as the leading vendors that are likely to dominate the market during the forecast period. This research report provides detailed analysis of market segmentation by program (HRA, nutrition &weight management, smoking cessation, fitness services, alcohol and drug rehab, stress management, health & education services, and others), by end-users (large private sector businesses, medium private sector businesses, public sector companies, small private sector businesses, non-profit organizations, hospitals/health systems, and universities), by revenue model (recurring revenues and seasonal revenues), by delivery model (onsite and offsite), and by geography (North America, Europe, APAC, and ROW).

The global corporate wellness market is anticipated to reach values of around $72 billion by 2023, growing at a CAGR of more than 8% during 2017-2023.

Request for your free sample here!

The global corporate wellness market is divided into five major segments that consist of program, end-users, revenue model, delivery model, and geography.

Stress management segment to grow at the fastest CAGR in the global corporate wellness market during the forecast period

The global corporate wellness market by the program is classified into HRA, nutrition & weight management, smoking cessation, fitness services, alcohol and drug rehab, stress management, health & education services, and others.

HRA segment dominated the largest market share in 2017, growing at a CAGR of more than 8% during the forecast period. With the rapid increase in healthcare costs, preventive care is gaining immense traction. The HRA segment is expected to grow at a stable pace as health risk assessments are considered among the most effective wellness programs by employers and employees alike, pegged at around 50%.

Stress management is the fastest growing segment in the global market, at a CAGR of over 9% during the forecast period. The extended hours, heavy workloads, and other issues at and outside of work are one of the primary factors attributing to the demand for stress management plans in the global market.

The increasing awareness about mental health and other related issues will encourage various organizations to implement effective stress management programs in the market.

These programs are designed to make employees feel in control of their health and happiness, resulting in growing demand in the global corporate wellness market. Linking cognitive behavioral therapy with smart phones is one of the top research areas in this market segment over the next few years. Anti-stress programs now include yoga, therapy, EAPs, social activities, child care initiatives, provision of work from home, flexible timings, and mindfulness training is gaining immense popularity in the market. The innovations happening through technology, assistance services, environmental innovations, and the range of activities will fuel the growth of the global corporate wellness market.

Medium private sector businesses to grow at a significant CAGR in the global corporate wellness market during the forecast period

The end-user segment in the global corporate wellness market is categorized into large private sector businesses, medium private sector businesses, public sector companies, small private sector businesses, non-profit organizations, hospitals/health systems, and universities. Medium private sector businesses dominated the second largest market share in 2017, growing at a CAGR of approximately 9% during the forecast period. The implementation of wellness programs primarily by healthcare costs in Western economies and talent attraction in regions such as the APAC is propelling the growth of this segment in the global market. The increasing popularity of HRAs, personalized health management, and biometric screenings across medium private sector businesses will fuel the revenues in the global corporate wellness market. Most of the medium private sector businesses are looking for a combination of primary interventions, screenings, and health education programs in the market. The growing need for a competitive benefits package that includes wellness programs will create lucrative opportunities for leading vendors operating in the global market. Leading vendors are offering enterprise-level programs for these businesses at cost-effective prices while remaining scalable to gain more global corporate wellness market share during the forecast period.

Looking for more information? Order a report now.

APAC to grow at a considerable CAGR in the global corporate wellness market during the forecast period

The global corporate wellness market by geography is segmented into North America, Europe, APAC, and ROW. APAC is the fastest growing region in the global market at a CAGR of around 9% during the forecast period. The increase in lifestyle risks such as lack of physical exercise, obesity, stress, poor nutrition, and tobacco use are some of the primary factors driving the need for well-designed wellness programs in the APAC market. Communication, financial management programs, tobacco control, EAPs, and flu vaccination programs are some of the most common programs that have a high demand in the APAC region in the global corporate wellness market. The growing demand for plans that support healthy eating, mental wellbeing, and aiding with managing the snooze hours better will encourage expansion in the APAC market. Organizations are implementing wellness plans that give employees access to quality, healthier spaces that facility performance, engagement, and wellbeing through adjustable furnishings, small cooking spaces, baths, and bike racks. Such benefits will augment the development of the global corporate wellness market.

Corporate wellness strategy in APAC

The other prominent players in the global corporate wellness market are Active Wellness, Aquila, BaySport, Beacon Health Options, Ceridian, Corporate Fitness Works, HealthFitness, Healthtrax, Health Systems Group, Integrated Wellness Partners, Kinema Fitness, LifeStart, LIVunLtd, Professional Fitness Management, Power Wellness, Reach Fitness, Marino Wellness, Midtown Athletic Club, The National Institute for Fitness and Sport (NIFS), OptumHealth, Privia Health,Premise Health, WTS International, Vitality Group, Wellsource, WISDOM WORKS GROUP, and WORKSTRIDE.

The complete overview of the latest market research report on the global corporate wellness market by Arizton is now available.

The report also offers a detailed study of major trends, drivers, challenges, and also provides the market size and forecast for major geographical regions and key countries.

Read more: https://www.arizton.com/market-reports/corporate-wellness-market

Jessica Shirley
Arizton Advisory and Inteligence
+1-312-465-7864
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn

Source: EIN Presswire

Dental implants in Reading are available from Berks County dentists at ADS

Affordable Dental Solutions offers the city of Reading dental implants that are high quality and low priced.

READING, PENNSYLVANIA, UNITED STATES, October 18, 2018 /EINPresswire.com/ — While other Berks County dentists may charge thousands for dental implants, the team of dentists at Affordable Dental Solutions in Reading strives to make sure high-quality dental care is affordable and accessible for patients.

Dental implants in Reading start at only $2,000. This low price includes the abutment and crown.

“Dental implants are so popular because they look and feel no different than a patient’s natural teeth,” explains Dr. Michelle Bernreuther, dentist in Reading.

In addition to dental implants, dentures in Reading are also available. Full dentures cost only $650 per arch while partial dentures cost only $750 per arch. Implant-retained dentures, which help stabilize existing dentures, are available for only $2,999 when two dental implants are added to a patient’s full lower dentures.

To learn more about dentures and dental implants available in Reading from ADS, request an appointment with the team of Berks County dentists today by visiting http://www.affordabledentalsolutions.com/request-appointment/. ADS also features locations in Easton, West Chester, Lansdale, and Pottstown.

About Affordable Dental Solutions: Based in Eastern Pennsylvania, Affordable Dental Solutions is a provider of full dentistry services. For nearly a decade, Affordable Dental Solutions has offered patients procedures such as dental implants, crowns, and dentures at rates much lower than area competitors by utilizing state-of-the-art equipment and by negotiating discounts with implant manufacturing companies. Learn more at https://www.affordabledentalsolutions.com/.

Jamie Jaskolka
Affordable Dental Solutions
(484) 948-2900
email us here

The History and Transformation of Affordable Dental Solutions in Reading

Source: EIN Presswire

DALLAS, TEXAS, UNITED STATES, October 18, 2018 /EINPresswire.com/ — Throughout the journey of life our experiences shape us and guide us to our destinies. For some individuals the challenges and adversities they face not only leads them the path of success and enlightenment it touches and inspires the lives of others.

Mary is an exceptional RN for 40 plus years and a naturopathic doctor.

“God has been my uplifting and calming rock and I have received many miracles from Him throughout my life,” says Mary. “In my early 20’s I was diagnosed with thyroid cancer and told I only had two months to live. And now 53 years later, I still talk, I sing, and I hold my head in any position I want, I take no Rx meds. It was all part of God’s miracles.”

Mary was born in West Virginia the daughter of a coal miner and the second oldest of nine children. Coming from an impoverished background her family moved around a lot and sometimes took residence in the woods. To keep food on the table Mary’s mother would pick wild weeds like dandelions, pokeweed, milkweed and managed to make a delectable feast for the entire family which essentially kept them well -nourished and healthy. When the family was able to afford “junk” food it actually caused them to become overweight and unhealthy.

“Although my mother expected us to quit school at the 8th grade and find jobs, I was determined to continue and get an education,” says Mary. “I also had a deep yearning and profound self-awareness to become closer to God and would spend a lot of time reading the Bible which further encouraged my pursuit of a higher education.”

In 1969 Mary went into nursing and resolutely inspired by how nourishing eating her mother’s weeds had been, she felt drawn to holistic medicine and ultimately became a naturopathic doctor and certified health practitioner, and took “Boot Camp” adventures in discovering, identifying and preparing the edible weeds of the forests. Today Mary strongly advocates for legalizing marijuana for medicinal purposes since the brain alone contains over 200 receptors for the cannabinoids.

“Marijuana makes you high when you burn it, but if you put it in a smoothie, or juice it, it is extremely healthy,” says Mary. “The government got a patent on Marijuana for medical use in 1936. Therefore, How and WHY is Marijuana classified as it is? Any plant that can has evidence of health benefits, cannot be classified as illegal. So, WHY is marijuana illegal?”

Mary also promotes the use of essential oils for magnificent healing effects that according to her can positively erase negative childhood memories that even years of therapy cannot overcome.

Currently Mary is writing a book hoping to raise awareness how God is authentic and has so profoundly touched her life and helped her heal.

“God loves us intensely and He is there for all of us,” says Mary. “He will eternally protect us, provide for us and He is my all and all and that’s why my life has been so fortunate and genuinely inspirational.”

CUTV News Radio will feature Mary Losh October 22nd at 12 p. m. EST in an interview with Jim Masters.

Listen to the show on BlogTalkRadio

If you have any questions for our guest please call (347) 996-3389.

Author: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook

Source: EIN Presswire